AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...
"Faux-tox" or fake botox is popping up across the country. With the allure of younger looking skin at discounted prices and through third parties, professionals are sending a warning about ...
Face taping is a skincare technique that has become viral in recent years. It involves taping specific areas of your face to help smooth and lift your skin to temporarily reduce the appearance of ...